Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Trobisch, A; Marterer, R; Gorkiewicz, G; Flaschberger, S; Lackner, H; Seidel, M; Sperl, D; Karastaneva, A; Kohlmaier, B; Egger, M; Urban, C; Benesch, M; Strenger, V.
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
Support Care Cancer. 2020; 28(5):2157-2161 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Benesch Martin
Egger Markus
Gorkiewicz Gregor
Karastaneva Anna
Kohlmaier Benno
Lackner Herwig
Marterer Robert
Seidel Markus
Sperl Daniela
Strenger Volker
Trobisch Andreas
Urban Ernst-Christian
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 2
| |
Abstract:
A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and intermittent additional posaconazole was continued until immune reconstitution 7 months after the end of ALL treatment. Repeated imaging guided treatment decisions. Twenty-six and 19 months after the end of ALL treatment and antifungal treatment, respectively, the patient is still in the first complete remission and shows no signs of active invasive fungal disease (IFD).

Find related publications in this database (Keywords)
ALL
Mucormycosis
IFD
Antimycotic treatment
Chemotherapy
© Med Uni Graz Impressum